SIGA Announces New Contract Awarded by U.S. Department of Defense for the Procurement of $9 Million of TPOXX®

NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company and leader in infectious diseases, today announced a new contract with the U.S. Department of Defense (DOD) for the procurement of approximately $9 million of TPOXX^® (Contract number: W911SR24C0030). This award is comprised primarily of oral TPOXX^®, with a small amount of intravenous (IV) TPOXX^®, and represents the third procurement contract award from the DOD over the past three years.